PT - JOURNAL ARTICLE AU - Folashade B. Agusto AU - Eric Numfor AU - Karthik Srinivasan AU - Enahoro Iboi AU - Alexander Fulk AU - Jarron M. Saint Onge AU - Townsend Peterson TI - Impact of public sentiments on the transmission of COVID-19 across a geographical gradient AID - 10.1101/2021.01.29.21250655 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.29.21250655 4099 - http://medrxiv.org/content/early/2021/02/17/2021.01.29.21250655.short 4100 - http://medrxiv.org/content/early/2021/02/17/2021.01.29.21250655.full AB - COVID-19 is a respiratory disease caused by a recently discovered, novel coronavirus, SARS-COV2. The disease has led to over 81 million confirmed cases of COVID-19, with close to 2 million deaths. In the current social climate, the risk of COVID-19 infection is driven by individual and public perception of risk and sentiments. A number of factors influences public perception, including an individual’s belief system, prior knowledge about a disease and information about a disease. In this paper, we develop a model for COVID-19 using a system of ordinary differential equations following the natural history of the infection. The model uniquely incorporates social behavioral aspects such as quarantine and quarantine violation. The model is further driven by people’s sentiments (positive and negative) which accounts for the influence of disinformation. People’s sentiments were obtained by parsing through and analyzing COVID-19 related tweets from Twitter, a social media platform across six countries. Our results show that our model incorporating public sentiments is able to capture the trend in the trajectory of the epidemic curve of the reported cases. Furthermore, our results show that positive public sentiments reduce disease burden in the community. Our results also show that quarantine violation and early discharge of the infected population amplifies the disease burden on the community. Hence, it is important to account for public sentiment and individual social behavior in epidemic models developed to study diseases like COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementThis research was supported byNational Science Foundation under the grant number DMS 2028297Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are publicly available